CSPC Pharmaceutical Group Ltd. has announced a change in the composition of its Nomination Committee. Ms. LI Quan, an independent non-executive director, has been appointed as a member of the committee, effective 27 June 2025. The Nomination Committee now consists of Mr. CAI Dong Chen (chairman), Mr. WANG Bo, Mr. CHEN Chuan, and Ms. LI Quan.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.